leadf
logo-loader
viewCineworld Group PLC

Market report: FTSE descends as nerves gather ahead of Chancellor Rishi Sunak’s new plan

There’s a sense of nervousness this morning in London, with a lower FTSE ahead of Chancellor Rishi Sunak’s plan to be unveiled later on today aimed at avoiding further unemployment as stricter Covid-19 restrictions come into force and to replace the furlough scheme next month.

Cineworld (LON:CINE) has reported a £1.3bn loss for the first half of the year because of the Covid-19 crisis, raising doubts over its ability to survive a second lockdown.

United Utilities Group PLC (LON:UU.) has said its profit are expected to be lower than the first half of last year due to lower water consumption from businesses.

Meanwhile Pet’s at Home (LON:PETS) has raised profit expectations after a strong summer. Profit are estimated to be ahead of market expectation for £73mln.

Integumen PLC (LON:SKIN) has unveiled a new coronavirus breath test, which it says has the potential to enable instant real-time testing for the virus. Directa Plus PLC (LON:DCTA) saw its first-half revenues treble despite the Covid-19.

And Trident Royalties (LON:TRR) has announced an acquisition plan - referred to as the Lake Rebecca Gold Project - there’s an interview up on proactiveinvestors.com with CEO Adam Davidson now.

Quick facts: Cineworld Group PLC

Price: 80.98 GBX

AIM:CINE
Market: AIM
Market Cap: £1.11 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Synairgen: Richard Marsden presents updates on all three Covid-19 treatment...

Synairgen PLC's (LON:SNG) Richard Marsden joins Proactive London's Katie Pilbeam to discuss three news updates so far this year.  Begining with the first patient dosed with its inhaled formulation of interferon beta-1a as part of its global phase III trial in people hospitalised...

4 minutes ago

2 min read